• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

F.D.A. Approves New Nasal Spray for Migraines
Pfizer ’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.
Source: NYT Health - March 10, 2023 Category: Consumer Health News Authors: Christina Jewett Tags: Migraine Headaches Drugs (Pharmaceuticals) Nerves and Nervous System Clinical Trials Food and Drug Administration Lancet Neurology, The (Journal) Pfizer Inc Source Type: news

No Increased Stroke Risk Linked to Pfizer ’s Covid Boosters, Federal Officials Say
An uptick hinted at in surveillance data was a mirage, the officials said.
Source: NYT Health - January 14, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Elderly Stroke Coronavirus Risks and Safety Concerns BioNTech SE Pfizer Inc Centers for Disease Control and Prevention Food and Drug Administration Source Type: news

New Treatment for Lou Gehrig ' s Disease Shows Promise
A study of their therapy and clinical trials of other experimental treatments are offering glimmers of hope that paralysis from the disorder can be slowed.
Source: NYT Health - September 2, 2020 Category: Consumer Health News Authors: Pam Belluck Tags: Amyotrophic Lateral Sclerosis Clinical Trials Research Drugs (Pharmaceuticals) ALS Assn Food and Drug Administration National Institute of Neurological Disorders and Stroke New England Journal of Medicine Koroshetz, Walter J your-feed-he Source Type: news

Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?
Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.
Source: NYT Health - December 7, 2019 Category: Consumer Health News Authors: Gina Kolata Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Sickle Cell Anemia Prices (Fares, Fees and Rates) Stroke Clinical Trials Hemoglobin Food and Drug Administration Novartis AG Global Blood Therapeutics Source Type: news

Experts Urge Sparing Use of Nonaspirin Painkillers
The Food and Drug Administration said it would ask drug manufacturers to change the labels to reflect evidence that nonaspirin, nonsteroidal anti-inflammatory drugs increased the risk of heart attacks and strokes.
Source: NYT Health - July 14, 2015 Category: Consumer Health News Authors: SABRINA TAVERNISE Tags: Pain-Relieving Drugs Heart Aleve (Drug) Celebrex (Drug) Drugs (Pharmaceuticals) Motrin IB Food and Drug Administration Labeling and Labels (Product) Stroke Ibuprofen (Drug) Source Type: news

F.D.A. Is Set to Toughen Nonaspirin Warnings
Labels on painkillers like ibuprofen that are taken by millions of Americans will be subtly changed to say that they cause an increased risk of heart attack and stroke.
Source: NYT Health - July 10, 2015 Category: Consumer Health News Authors: SABRINA TAVERNISE Tags: Drugs (Pharmaceuticals) Food and Drug Administration Labeling and Labels (Product) Source Type: news

Drugs Using Testosterone Will Label Heart Risks
The F.D.A. ordered that labels on testosterone drugs warn of heart attack and stroke risks, and advised that the drugs should not be prescribed to treat symptoms in men brought on by age, such as declining sexual drive.
Source: NYT Health - March 4, 2015 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Drugs (Pharmaceuticals) Food and Drug Administration Labeling and Labels Testosterone Source Type: news